Genprex, Inc. (GNPX) Stock Ticker
Market factors today
Unlock the full GNPX picture
About Genprex, Inc.
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer. In addition, Genprex is progressing GPX-002, another gene therapy at the preclinical stage, intended for the management of diabetes. The company was established in 2009 and operates from its corporate headquarters located in Austin, Texas.
GNPX stock facts
| Ticker symbol | GNPX |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.7M |
| CEO | Ryan Confer |
| Employees | 13 |
| Headquarters | Austin, TX, US |
| IPO date | 2018-03-29 |
| Website | www.genprex.com |
What you can see for GNPX on Tickr
Live GNPX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the GNPX report.
Rankings
FAQ
What is the ticker symbol for Genprex, Inc.?
The ticker symbol for Genprex, Inc. is GNPX, listed on the NASDAQ Capital Market.
What is GNPX?
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer…